Dent Disease is a rare kidney condition. It causes the kidneys to produce too much calcium, not enough phosphate, and calcium deposits in the kidneys. This can lead to kidney stones and kidney damage over time. It's usually inherited, meaning it runs in families.
Every report comes from a Lived member, sent anonymously.
Have you tried Hydrochlorothiazide (HCTZ) for Dent Disease?
Dent disease is a rare inherited kidney disorder that affects the proximal tubules, the first stretch of the kidney's tiny filtering units, where the body normally reclaims proteins, minerals and other useful substances before they are lost in urine. In Dent disease this recovery system works poorly. Small proteins leak into the urine, and the urine usually carries too much calcium (hypercalciuria). Over the years, the extra calcium can form kidney stones and calcium deposits within the kidney tissue itself (nephrocalcinosis), and kidney function slowly declines, often reaching kidney failure in adulthood. The condition occurs almost exclusively in boys and men. Many have no symptoms for years, and the diagnosis often begins with a routine urine test that happens to show protein. Others come to attention through kidney stones, softened bones (rickets in children, osteomalacia in adults) or reduced kidney function with no obvious cause. How severe it becomes varies widely, even among relatives.
Dent disease is caused by changes (variants) in genes on the X chromosome. About half to 60% of people with it have a variant in the CLCN5 gene, which is called Dent disease 1. About 15% have a variant in the OCRL gene, called Dent disease 2. This form has the same kidney problems and more often has mild effects elsewhere, such as shorter height, mild learning or developmental delays and, occasionally, a cataract (clouding of the eye's lens) present from birth. In roughly a quarter to a third of people, no variant is found in either gene, and other genes are probably involved. Nothing a person does causes Dent disease. Because males have one X chromosome, a single altered copy is enough to cause the disease. Females have two X chromosomes and are usually carriers. More than half of carriers lose small amounts of protein in their urine, about 30% have high urine calcium, and some develop kidney stones later in life, but kidney failure in women is extremely rare. A carrier mother has a 50% chance of passing the variant on in each pregnancy: a son who inherits it is affected, and a daughter becomes a carrier. An affected father passes it to all of his daughters and to none of his sons. In some families the variant arose new (de novo) and the parents do not carry it. Genetic counseling helps families work out who may be at risk and which testing makes sense.
Because early Dent disease rarely causes obvious symptoms, it is easy to miss. The key clue is the type of protein in the urine. In most kidney diseases that leak protein, the leak comes through the kidney's filters, and the urine contains mainly albumin, a large blood protein. In Dent disease the leak comes from the tubules, so the urine is dominated by small (low-molecular-weight) proteins such as retinol-binding protein or alpha-1-microglobulin. Everyone with Dent disease has this pattern, so a urine test for these small proteins is the first crucial step. High urine calcium, usually measured as a calcium-to-creatinine ratio on a urine sample, strongly supports the diagnosis. It is less common in adults whose kidney function has already declined and in patients from East Asia, so its absence does not rule Dent disease out. Protein loss can be heavy, sometimes in the range usually seen with nephrotic syndrome, a condition in which the kidney filters leak so much protein that blood albumin falls and swelling develops. In Dent disease, blood albumin is usually normal and there is no swelling. Missing this difference has led to misdiagnosis as a hard-to-treat form of nephrotic syndrome, so experts recommend testing for small-protein loss before any kidney biopsy, and not doing a biopsy once Dent disease is suspected. Genetic testing of the CLCN5 and OCRL genes confirms the diagnosis and tells the two types apart. In about 20 to 25% of people with a clear clinical picture no variant is found, so a negative result does not exclude Dent disease. The wider evaluation usually includes blood tests of kidney function, potassium, phosphate, vitamin D and bone health, and a kidney ultrasound to look for stones and calcium deposits.
There is no cure, and no treatment has yet been shown to prevent kidney stones or slow the loss of kidney function in Dent disease. The condition is rare and changes over decades, which makes clinical trials difficult, so current recommendations come from expert consensus, animal studies and experience with related conditions. Care focuses on replacing what the kidneys are losing, protecting bones and growth, and preparing for kidney failure if it comes. Potassium citrate, a prescription alkali taken by mouth, may be offered, particularly to people with stones or calcium deposits. Citrate helps prevent calcium stones in other conditions and slowed kidney damage in mice with Dent disease, but it has not been tested in people with Dent disease. It makes urine less acidic, so urine pH is checked, because overly alkaline urine can favor a different type of calcium stone. Low blood phosphate with signs of rickets or osteomalacia may be treated with more dietary phosphate or phosphate supplements, with urine calcium and kidney ultrasounds monitored, since extra phosphate in the urine can add to stone risk. Ordinary vitamin D may be given if levels are low. Active vitamin D (calcitriol), used for some other forms of rickets, is avoided because the body already makes plenty of it in Dent disease and it can push urine calcium even higher. Because the protein that carries vitamin A is lost in urine, vitamin A is replaced if levels turn out low. Growth hormone may be considered for children whose growth stays poor despite these measures or whose kidney function is significantly reduced. Some treatments used for other kidney problems are not routine here. Thiazide water pills lower urine calcium in short-term studies, but long-term benefit is unproven, and they can cause dehydration and salt imbalances; people with Dent disease 2 are especially prone to severe dehydration and sudden kidney injury on them. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers, blood pressure medicines often used to cut protein loss in other kidney diseases, have not reduced protein in the urine in Dent disease, which fits with the protein coming from the tubules rather than the filters. They are not recommended routinely to protect the kidneys, and when they are prescribed, the expected benefit is weighed against risks such as low blood pressure. If kidney failure develops, dialysis or a kidney transplant is needed. Dent disease does not come back in a transplanted kidney. Because a mother and some sisters may be carriers, a relative's suitability as a living donor needs careful assessment; a father or an unaffected brother can donate safely.
Dent disease is lifelong, and its course varies greatly, even between relatives with the same genetic change. Many children feel well, and the condition may be known only from urine tests. Calcium deposits in the kidneys often appear in childhood, while kidney stones tend to come later. Kidney function usually declines slowly over decades. Between 30% and 80% of affected men reach kidney failure, typically somewhere between their 30s and 50s, while others keep useful kidney function longer. Neither the amount of protein in the urine nor the extent of calcium deposits predicts how fast this happens. Follow-up is regular rather than intensive for most people: blood and urine tests every 3 to 6 months and a kidney ultrasound about once a year, with closer monitoring as kidney function falls. Experts recommend shared care between a local kidney specialist (nephrologist) and a center experienced with Dent disease, which can also coordinate genetic counseling, stone care and, for children, growth assessment. Children with Dent disease 2 may need eye checks for cataract and support with learning or development. Female carriers are advised to have their kidney function, urine and a kidney ultrasound checked at least once as adults.
Ask about evaluation for Dent disease when a boy or man has protein in the urine with normal blood albumin and no swelling, high urine calcium, kidney stones or calcium deposits at a young age, rickets, or reduced kidney function without a clear cause, especially if male relatives on the mother's side have had kidney failure. Women in an affected family can ask about carrier testing and a kidney check. If Dent disease is already diagnosed, tell the care team about night blindness or dry eyes, which can signal vitamin A deficiency, and about bone pain, bowing of the legs or slowing growth in a child. Seek same-day medical care for severe back or side pain that will not ease, or pain with fever and chills, vomiting or blood in the urine, since a kidney stone may be stuck and blocking the flow of urine.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Dent Disease is like, what's helped you, or ask the community a question.